Compare LAB & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAB | PSNYW |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | Sweden |
| Employees | 389 | 1686 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Manufacturing |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.2M | 321.7M |
| IPO Year | 2008 | N/A |
| Metric | LAB | PSNYW |
|---|---|---|
| Price | $0.83 | $2.79 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 95.6K |
| Earning Date | 05-05-2026 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.54 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | $101,937,000.00 | ★ $2,034,261,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | $79.49 |
| P/E Ratio | $2.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.15 |
| 52 Week High | $1.72 | $9.08 |
| Indicator | LAB | PSNYW |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 51.21 |
| Support Level | $0.79 | $2.48 |
| Resistance Level | $1.01 | $3.66 |
| Average True Range (ATR) | 0.07 | 0.64 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 30.41 | 10.90 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.